UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 747

Sortiert nach

Dose–response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man

Anesthesiology (Philadelphia), 2016-12, Vol.125 (6), p.1136-1143

2016

Volltextzugriff (PDF)

Novel neuromuscular blocking drugs and antagonists

Current opinion in anaesthesiology, 2015-08, Vol.28 (4), p.403-410

2015

Volltextzugriff (PDF)

Clinical pharmacology of GW280430A in humans

Anesthesiology (Philadelphia), 2004-04, Vol.100 (4), p.768-773

2004

Volltextzugriff (PDF)

Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs

Anesthesiology (Philadelphia), 2010-04, Vol.112 (4), p.910-916

2010

Volltextzugriff (PDF)

Gantacurium and CW002 Do Not Potentiate Muscarinic Receptor-mediated Airway Smooth Muscle Constriction in Guinea Pigs

Anesthesiology (Philadelphia), 2010-04, Vol.112 (4), p.892-899

2010

Volltextzugriff (PDF)

Multimodal analgesia as an alternative to the risks of opioid monotherapy in surgical pain management

Journal of healthcare risk management, 2017-07, Vol.37 (1), p.24-30

2017

Volltextzugriff (PDF)

Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine

Anesthesiology (Philadelphia), 2018-11, Vol.129 (5), p.970-988

2018

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

Anesthesiology (Philadelphia), 2018-06, Vol.128 (6), p.1107-1116

2018

Volltextzugriff (PDF)

Moving the field: the sensorimotor perspective on autism (Commentary on "Rethinking autism: implications of sensory and motor differences," an article by Anne Donnellan, David Hill, and Martha Leary)

Frontiers in integrative neuroscience, 2013-01, Vol.7, p.6-6

Savarese, Ralph J

2013

Volltextzugriff (PDF)

The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Anesthesiology (Philadelphia), 1995-05, Vol.82 (5), p.1131-1138

1995

Volltextzugriff (PDF)

The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short-acting Nondepolarizing Ester Neuromuscular Blocking Drug

Anesthesiology (Philadelphia), 1988-05, Vol.68 (5), p.723-732

1988

Volltextzugriff (PDF)

Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs

Anesthesiology (Philadelphia), 2004-04, Vol.100 (4), p.846-851

2004

Volltextzugriff (PDF)

Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat

Anesthesiology (Philadelphia), 2016-10, Vol.125 (4), p.732-743

2016

Volltextzugriff (PDF)

Fumarates: Unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine

Journal of critical care, 2009-03, Vol.24 (1), p.50-57

2009

Volltextzugriff (PDF)

The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Anesthesiology (Philadelphia), 1995-05, Vol.82 (5), p.1139-1145

1995

Volltextzugriff (PDF)

Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles

Journal of pharmacological and toxicological methods, 2011-09, Vol.64 (2), p.111-118

2011

Volltextzugriff (PDF)

Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium

Anesthesiology (Philadelphia), 2004-04, Vol.100 (4), p.835-845

2004

Volltextzugriff (PDF)

Rapid Chemical Antagonism of Neuromuscular Blockade by L-Cysteine Adduction to and Inactivation of the Olefinic (Double-bonded) Isoquinolinium Diester Compounds Gantacurium (AV430A), CW 002, and CW 011

Anesthesiology (Philadelphia), 2010-07, Vol.113 (1), p.58-73

2010

Volltextzugriff (PDF)

Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats

Anesthesiology (Philadelphia), 1996-07, Vol.85 (1), p.169-177

1996

Volltextzugriff (PDF)

Optimizing Safety in a Radiation Oncology Department Through Improving Timeliness of Treatment Planning Care Path

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S111-S112

2021

Volltextzugriff (PDF)

Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs: Pharmacodynamics, Acute Cardiovascular Effects, and Preliminary Toxicology

Anesthesiology (Philadelphia), 2010-04, Vol.112 (4), p.900-909

2010

Volltextzugriff (PDF)

Bis- and Mixed-Tetrahydroisoquinolinium Chlorofumarates: New Ultra-Short-Acting Nondepolarizing Neuromuscular Blockers

Journal of medicinal chemistry, 1999-01, Vol.42 (2), p.206-209

1999

Volltextzugriff (PDF)

Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Anesthesiology (Philadelphia), 1996-02, Vol.84 (2), p.300-308

1996

Volltextzugriff (PDF)

Warming up the "chilling effect": A comment on the motive clause discussions in 'R v Khawaja' (2010) and 'R v Khawaja' (2012)

The Windsor yearbook of access to justice, 2012-10, Vol.30 (2), p.199-224

Savarese, JL

2012

Volltextzugriff (PDF)

Neuromuscular Blocking Activity and Therapeutic Potential of Mixed-Tetrahydroisoquinolinium Halofumarates and Halosuccinates in Rhesus Monkeys

Journal of medicinal chemistry, 2003-06, Vol.46 (12), p.2502-2515

2003

Volltextzugriff (PDF)

1 – 25 von 747

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(652)
Mit Volltextzugriff
(697)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(380)
Life Sciences & Biomedicine
(320)
Humans
(253)
Medicin Och Hälsovetenskap
(169)
Cardiovascular System & Cardiology
(131)
Cardiac & Cardiovascular Systems
(124)
Male
(99)
Female
(94)
Biological And Medical Sciences
(77)
Anesthesiology
(75)
Heart Failure
(75)
Middle Aged
(73)
Medical Sciences
(71)
Adult
(69)
Aged
(67)
Animals
(52)
Pharmacology. Drug Treatments
(36)
Technology
(34)
Time Factors
(34)
Dose-Response Relationship, Drug
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Dose–response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man

Novel neuromuscular blocking drugs and antagonists

Clinical pharmacology of GW280430A in humans

Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs

Gantacurium and CW002 Do Not Potentiate Muscarinic Receptor-mediated Airway Smooth Muscle Constriction in Guinea Pigs

Multimodal analgesia as an alternative to the risks of opioid monotherapy in surgical pain management

Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine

Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

Moving the field: the sensorimotor perspective on autism (Commentary on "Rethinking autism: implications of sensory and motor differences," an article by Anne Donnellan, David Hill, and Martha Leary)

The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia

The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short-acting Nondepolarizing Ester Neuromuscular Blocking Drug

Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs

Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat

Fumarates: Unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine

The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles

Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium

Rapid Chemical Antagonism of Neuromuscular Blockade by L-Cysteine Adduction to and Inactivation of the Olefinic (Double-bonded) Isoquinolinium Diester Compounds Gantacurium (AV430A), CW 002, and CW 011

Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats

Optimizing Safety in a Radiation Oncology Department Through Improving Timeliness of Treatment Planning Care Path

Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs: Pharmacodynamics, Acute Cardiovascular Effects, and Preliminary Toxicology

Bis- and Mixed-Tetrahydroisoquinolinium Chlorofumarates: New Ultra-Short-Acting Nondepolarizing Neuromuscular Blockers

Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Warming up the "chilling effect": A comment on the motive clause discussions in 'R v Khawaja' (2010) and 'R v Khawaja' (2012)

Neuromuscular Blocking Activity and Therapeutic Potential of Mixed-Tetrahydroisoquinolinium Halofumarates and Halosuccinates in Rhesus Monkeys

Suchergebnisse filtern